Searched for
SYMBIOTEC PHARMALAB IPO NEWS
Global Market: Shein valuation falls 70% from peak as Hong Kong IPO targets $1.77 billionShein launched its Hong Kong IPO at a valuation of up to $27 billion, around 70% below its 2022 peak, as slowing growth, rising costs and r...- Avaada said to plan public filing for $800 million IPOAvaada Electro is gearing up for an initial public offering aiming to raise up to $800 million. The solar manufacturing company has partner...
- Symbiotec Pharmalab’s Rs 1,757 crore IPO opens with GMP hinting at 41% upside. Should you bid?Symbiotec Pharmalab IPO GMP: Symbiotec Pharmalab’s Rs 1,757 crore IPO opened August 24, with a Rs 938–988 price band and 41% grey-market pr...
- Lalithaa Jewellery Mart shares shine on debut, list at 32% premium over IPO priceLalithaa Jewellery Mart Share Price: Lalithaa Jewellery Mart made a remarkable entrance on Monday, entering the stock market with a strong ...
- Tempsens Instruments IPO Day 3: Issue sees robust demand as GMP soars 105%, subscription hits 38 timesTempsens Instruments IPO saw strong investor demand, while the latest grey market premium (GMP) indicated a potential 105% listing premium....
- Fascinate Textiles shares list at 20% discount to issue price of Rs 151 on NSE SME platformFascinate Textiles shares made a weak NSE SME debut on August 24, listing at a 20% discount to the IPO price despite the issue being subscr...
- Hy-Tech Engineers IPO opens today: GMP signals 47% listing premium. Should you subscribe?Hy-Tech Engineers IPO: The Rs 135.73-crore issue set to remain open until August 27. The IPO comprises a fresh issue of Rs 60 crore and an ...
- Rs 21,000 crore IPO rush in August highest in one year. Will September break all records?In August, India's IPO market witnessed a remarkable recovery, becoming the most active month in nearly a year. Over twenty companies succe...
- IPO rush continues: 10 issues to raise over Rs 3,500 crore this weekThis week sees the launch of six mainboard IPOs and four from the SME sector, with total fundraising expected to surpass Rs 3,500 crore. Am...
- Can Symbiotec Pharmalab IPO deliver long-term growth for high-risk investors?Symbiotec Pharmalab plans a ₹150 crore IPO to repay debt and expand operations. The company holds a global leadership position in corticost...
- Rs 3,300 crore IPO week: Symbiotec, Skyways Air to lead 10-offer rush for investorsIndia's IPO market is set for a busy week, with 10 companies, including Symbiotec Pharmalab, Skyways Air Services, Hy-Tech Engineers and Lu...
- 20 IPOs on investors' radar next week. GMPs indicate up to 90% returnsA total of 20 IPOs are on investors’ radar next week, including fresh issues and upcoming listings across the mainboard and SME segments. S...
- Symbiotec Pharmalab gets Rs 526 crore anchor backing ahead of IPO; Citi Group, Singularity among investorsSymbiotec Pharmalab has raised Rs 526.20 crore from anchor investors ahead of its Rs 1,757 crore IPO opening August 24. The pharmaceutical ...
- Online Instruments India gets Sebi approval to float IPOOnline Instruments has successfully secured Sebi approval for its initial public offering. The firm is set to issue new equity shares along...
- Mom’s Belief operator files IPO papers with Sebi, to fund 319 new child therapy centresRays of Belief, operating under the Mom’s Belief brand, has filed its DRHP with Sebi for an IPO comprising a fresh issue of up to 52.30 lak...
- Tiger Global-backed broking firm Upstox said to plan India IPOUpstox is currently in talks with investment banks regarding a possible initial public offering. Backed by Tiger Global, the company plans ...
- Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 1...
- Anthropic pre-IPO credit facility set to climb past $10 billionAnthropic is broadening its revolving credit facility past the initial target to prepare for its much-anticipated initial public offering. ...
- Aarti Pharmalabs shares rally over 33% in two days post Q1 results. What is driving the surge?Aarti Pharmalabs shares have surged 33% in two days after the company reported a 65.4% year-on-year rise in Q1FY27 profit and 38.7% growth ...
- Aarti Pharmalabs shares hit 20% upper circuit as Q1 net profit surges 65% YoY to Rs 76 croreAarti Pharmalabs shares hit the 20% upper circuit after the company reported a 65.4% year-on-year rise in Q1 FY27 net profit to Rs 76.14 cr...
Load More
